We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Next Generation Automated Liquid Handling and Sample Preparation System Available in 2013

By LabMedica International staff writers
Posted on 15 Nov 2012
An innovative automatic liquid handling system will shortly be available for biotech and other life science laboratories.

The Agilent Technologies Inc. More...
(Santa Clara, CA, USA) Encore Multispan Liquid Handling System is expected to be ready for shipping in the second quarter of 2013.

This state-of-the-art instrument boasts a dual, multispan pipetting system that provides two individual banks of multiple pipettes where each moves independently in multiple axes, delivering ultimate speed and double the throughput of other automated liquid handling platforms available today. Each pipette is compatible with a variety of sample formats, from test tubes to vials to microplates.

The platform incorporates an innovative and powerful software package that features a three-dimensional simulator that provides the operator with the ability to set up, visualize, and optimize liquid delivery protocols remotely and offline prior to running them on the system.

The Encore Multispan Liquid Handling System was designed for a wide range of applications, including high-throughput screening, ELISA, drug discovery, compound management, and sample-preparation workflows for genomics, proteomics, and more.

“Agilent’s distinct expertise in both workflow automation and liquid handling has allowed us to integrate innovative technologies into a single platform, and empower scientists to take their research to the next level in terms of flexibility, throughput, and ultimately lab productivity,” said Yvonne Linney, vice president and general manager of automation solutions at Agilent. “With the introduction of the Encore Multispan System, Agilent is offering scientists the ability to reach beyond routine liquid handling and experience the highest levels of efficiency and productivity in their laboratories.”

“In partnership with our customers, we worked to understand the many bottlenecks and limitations associated with sample-prep automation and created a unique solution,” said Ms. Linney. “It combines advanced liquid handling and robotics to enable true sample-to-analysis automation.”

Related Links:
Agilent Technologies Inc.



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.